Transactivation of EGF receptors in chicken müller cells by a2A-adrenergic receptors stimulated by brimonidine

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 6, 2014, Pages 3385-3394

  Harun Or, Mohammad Rashid ^a   Lindqvist, Niclas ^a   Hallböok, Finn ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alpha2 adrenergic agonists; EGF receptor; Metalloproteinases; M ller cells; Transactivation

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL) PYRAZOLO [3, 4 D] PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL) PYRAZOLO [3, 4 D] PYRIMIDINE; BRIMONIDINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE P60; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR STRESS RESPONSE; CHICK EMBRYO; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENSITOMETRY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; WESTERN BLOTTING;

ALPHA2-ADRENERGIC AGONISTS; EGF RECEPTOR; METALLOPROTEINASES; MÜLLER CELLS; TRANSACTIVATION;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHICK EMBRYO; EPENDYMOGLIAL CELLS; GLAUCOMA; IMMUNOHISTOCHEMISTRY; MAP KINASE SIGNALING SYSTEM; QUINOXALINES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ADRENERGIC, ALPHA-2; RETINA; RNA; TRANSCRIPTIONAL ACTIVATION;

EID: 84901917053     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13823     Document Type: Article

References (41)

1. Bringmann A, Pannicke T, Grosche J, et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006;25:397-424.
2. Dyer MA, Cepko CL. Control of Muller glial cell proliferation and activation following retinal injury. Nat Neurosci. 2000;3: 873-880.
3. Fischer AJ, Reh TA. Muller glia are a potential source of neural regeneration in the postnatal chicken retina. Nat Neurosci. 2001;4:247-252.
4. Karl MO, Hayes S, Nelson BR, et al. Stimulation of neural regeneration in the mouse retina. Proc Natl Acad Sci U S A. 2008;105:19508-19513.
5. Osakada F, Ooto S, Akagi T, et al. Wnt signaling promotes regeneration in the retina of adult mammals. J Neurosci. 2007; 27:4210-4219.
6. Wan J, Ramachandran R, Goldman D. HB-EGF is necessary and sufficient for Muller glia dedifferentiation and retina regeneration. Dev Cell. 2012;22:334-347.
7. Fischer AJ, Scott MA, Ritchey ER, Sherwood P. Mitogenactivated protein kinase-signaling regulates the ability of Muller glia to proliferate and protect retinal neurons against excitotoxicity. Glia. 2009;57:1538-1552.
8. Fischer AJ, Scott MA, Tuten W. Mitogen-activated protein kinase-signaling stimulates Muller glia to proliferate in acutely damaged chicken retina. Glia. 2009;57:166-181.
9. Wen R, Cheng T, Li Y, Cao W, Steinberg RH. Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci. 1996;16:5986-5992.
10. Yoles E, Wheeler LA, Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci. 1999;40:65-73.
11. Lafuente MP, Villegas-Perez MP, Sobrado-Calvo P, et al. Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci. 2001;42:2074-2084.
12. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA. Neuroprotection of retinal ganglion cells by brimonidine in rats with laserinduced chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42:2849-2855.
13. Dong CJ, Guo Y, Agey P, Wheeler L, Hare WA. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Invest Ophthalmol Vis Sci. 2008;49: 4515-4522.
14. Gao H, Qiao X, Cantor LB, WuDunn D. Up-regulation of brainderived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch Ophthalmol. 2002;120:797-803.
15. Lonngren U, Napankangas U, Lafuente M, et al. The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment. Brain Res Bull. 2006;71:208-218.
16. Peng M, Li Y, Luo Z, et al. Alpha2-adrenergic agonists selectively activate extracellular signal-regulated kinases in Muller cells in vivo. Invest Ophthalmol Vis Sci. 1998;39:1721-1726.
17. Hawes BE, van Biesen T, Koch WJ, Luttrell LM, Lefkowitz RJ. Distinct pathways of Gi-and Gq-mediated mitogen-activated protein kinase activation. J Biol Chem. 1995;270:17148-17153.
18. Daunt DA, Hurt C, Hein L, et al. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol. 1997;51:711-720.
19. Woldemussie E, Wijono M, Pow D. Localization of alpha 2 receptors in ocular tissues. Vis Neurosci. 2007;24:745-756.
20. Greenfield DS, Liebmann JM, Ritch R. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment. J Glaucoma. 1997;6:250-258.
21. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-proteincoupled receptors. Nature. 1996;379:557-560.
22. Pierce KL, Tohgo A, Ahn S, et al. Epidermal growth factor (EGF) receptor-dependent ERK activation by G proteincoupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J Biol Chem. 2001;276:23155-23160.
23. Roque RS, Caldwell RB, Behzadian MA. Cultured Muller cells have high levels of epidermal growth factor receptors. Invest Ophthalmol Vis Sci. 1992;33:2587-2595.
24. Boije H, Harun-Or-Rashid M, Lee YJ, et al. Sonic Hedgehogsignalling patterns the developing chicken comb as revealed by exploration of the pea-comb mutation. PLoS One. 2012;7: e50890.
25. Verwaerde P, Tran MA, Montastruc JL, Senard JM, Portolan G. Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension. Fundam Clin Pharmacol. 1997;11:567-575.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods. 2001;25:402-408.
27. Ka S, Markljung E, Ring H, et al. Expression of carnitine palmitoyl-CoA transferase-1B is influenced by a cis-acting eQTL in two chicken lines selected for high and low body weight. Physiol Genomics. 2013;45:367-376.
28. Ochrietor JD, Moroz TP, Linser PJ. The 2M6 antigen is a Muller cell-specific intracellular membrane-associated protein of the sarcolemmal-membrane-associated protein family and is also TopAP. Mol Vis. 2010;16:961-969.
29. Yamagata K, Goto K, Kuo CH, Kondo H, Miki N. Visinin: a novel calcium binding protein expressed in retinal cone cells. Neuron. 1990;4:469-476.
30. Hanke JH, Gardner JP, Dow RL, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck-and FynT-dependent T cell activation. J Biol Chem. 1996;271:695-701.
31. Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, Lefkowitz RJ. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J Biol Chem. 1997;272:4637-4644.
32. Karkoulias G, Mastrogianni O, Lymperopoulos A, Paris H, Flordellis C. Alpha(2)-adrenergic receptors activate MAPK and Akt through a pathway involving arachidonic acid metabolism by cytochrome P450-dependent epoxygenase, matrix metal-loproteinase activation and subtype-specific transactivation of EGFR. Cell Signal. 2006;18:729-739.
33. Santiskulvong C, Rozengurt E. Galardin (GM 6001), a broadspectrum matrix metalloproteinase inhibitor, blocks bombesin-and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells. Exp Cell Res. 2003;290:437-446.
34. Han Y, Caday CG, Nanda A, Cavenee WK, Huang HJ. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. Cancer Res. 1996;56:3859-3861.
35. Kalapesi FB, Coroneo MT, Hill MA. Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection. Br J Ophthalmol. 2005;89:758-763.
36. Li B, Du T, Li H, et al. Signalling pathways for transactivation by dexmedetomidine of epidermal growth factor receptors in astrocytes and its paracrine effect on neurons. Br J Pharmacol. 2008;154:191-203.
37. Du T, Li B, Liu S, et al. ERK phosphorylation in intact, adult brain by alpha(2)-adrenergic transactivation of EGF receptors. Neurochem Int. 2009;55:593-600.
38. Rojas M, Yao S, Lin YZ. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cellpermeable peptide mimicking phosphorylated EGF receptor. J Biol Chem. 1996;271:27456-27461.
39. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402:884-888.
40. Gutwein P, Oleszewski M, Mechtersheimer S, et al. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. J Biol Chem. 2000;275: 15490-15497.
41. Nakazawa T, Shimura M, Ryu M, et al. ERK1 plays a critical protective role against N-methyl-D-aspartate-induced retinal injury. J Neurosci Res. 2008;86:136-144.